1. Introduction
===============

Colorectal cancer (CRC) is a global public health concern, with an increasing incidence and mortality rates in the developing countries.^\[[@R1]\]^ Various estimates indicate that CRC incidence is increasing in countries with limited healthcare resources, particularly in Latin America and Eastern Europe.^\[[@R2]\]^ Worldwide, CRC is the third leading cause of cancer mortality in men and the second in women.^\[[@R3]\]^ Certain demographic features associated with the disease differ between world regions such as distribution by sex, age, and race. For example, CRC is more commonly diagnosed in older individuals and in men in most of the developed countries, its incidence is higher in African Americans, and higher CRC mortality is often associated with lower socioeconomic status.^\[[@R4]--[@R6]\]^ Environmental exposures, and personal and family history of colorectal polyps^\[[@R7]--[@R11]\]^ and cancer^\[[@R12]\]^ are both known risk factors for CRC development. CRC outcomes depend primarily on the distribution and spread of the disease, and also early diagnosis and intervention.^\[[@R13]\]^

In Colombia, an upper-middle income country with the third largest population in Latin America, CRC is the fourth most common cause of cancer incidence and mortality with age-standardized rates (ASRs) for incidence 13.4 and 12.5 per 100,000 among men and women, respectively, and mortality ASR 7.6 and 7.0 per 100,000 for men and women, respectively.^\[[@R14]\]^ These rates reflect a significant increase in the CRC incidence in Colombia when compared with previous years.^\[[@R15]\]^ Furthermore, mortality trends in this country show a significant increase for both sexes.^\[[@R16]\]^ Despite the associated burden, scarce data are available on clinical characteristics of CRC in Colombia and Hispanic populations, which have unique admixed American Indian, African, and European origin.^\[[@R17]--[@R20]\]^ Therefore, the goal of this multicenter study was to describe the clinicopathological characteristics of a large cohort of Colombian CRC cases.^\[[@R21]--[@R23]\]^ The data gathered in our study, which, to our knowledge, are the largest in Hispanics from Latin America or the United States, will be useful to support future research and to inform prevention and screening programs in these populations.

2. Materials and methods
========================

2.1. Study population
---------------------

A total of 1525 CRC-incident cases diagnosed between 2006 and 2014 were enrolled as part of ongoing CRC genetic studies in Colombia.^\[[@R21]--[@R23]\]^ Cases were recruited through large cancer hospitals in 10 of largest Colombian cities (Cartagena, Santa Marta, Barranquilla, Cali, Pasto, Medellin, Bucaramanga, Bogota, Ibague, Neiva), and hence the study population is representative of most major geographical regions in the country and where most of Colombians are settled. The study adhered to the Helsinki Declaration and received IRB approvals from University of Tolima and Instituto Nacional de Cancerologia (Colombian National Cancer Institute), and also from ethic committees at the clinical centers when required (University of Tolima, Hospital Federico Lleras Acosta, Hospital Hernando Moncaleano Perdomo, Hospital Pablo Tobon Uribe, and multiple private oncology centers).

2.2. Demographic and clinical data
----------------------------------

After providing informed consent, patients were interviewed in person by trained research nurses. A questionnaire was completed and information was collected about sociodemographic characteristics, height, weight, smoking and drinking habits, and family history of cancer. Using the questionnaire and histopathology reports, we obtained information about sex, age at diagnosis (in years), family history of cancer in first and second-degree relatives, histological subtype, degree of differentiation, tumor location (see below), presence of synchronous or metachronous colorectal and extracolorectal tumors, type of resection (right, left, rectum), number of positive lymph nodes, and the tumor, lymph node, metastasis (TNM) stage. The histopathological re-classification was performed according to the latest recommendations of the World Health Organization.^\[[@R24]\]^ Tumor location was determined as proximal (cecum, appendix, ascending colon, hepatic flexure, and transverse colon), distal (splenic flexure, descending colon, and sigmoid colon), or rectal.

2.3. Statistical analyses
-------------------------

We stratified patients by age of diagnosis or by sex. Those with CRC by age of 50 years were classified as early-onset cases and those diagnosed with CRC \>50 years were classified as having late-onset disease. Chi-square tests were used to explore associations between age of onset or sex and clinical variables. For cases with histopathology reports from surgical resections (n = 543 cases), we also explored associations between age of onset, and sex and histological variables such as tumor stage, presence or absence of lymph node metastasis, and TNM. Data were analyzed using the R software.^\[[@R25]\]^

3. Results
==========

3.1. Demographic and clinical features of the study cohort
----------------------------------------------------------

Table [1](#T1){ref-type="table"} shows the main clinical and histological characteristics of the 1525 CRC cases analyzed in our study. We found a significantly higher number of female cases than that of male cases in our study (811 female cases and 714 male cases; *P* = 0.009; Table [1](#T1){ref-type="table"}). The average age at CRC diagnosis in the cohort was 57.4 years (range 19--75 years), with men and women having similar average age at diagnosis (57 and 58 years, respectively; data not shown). Four hundred five cases had early-onset disease and 1120 were late-onset cases. Of the late-onset cases, 37% were diagnosed between ages 51 and 60 years, and 63% \>60 years (data not shown). At the time of diagnosis, 50.8% of these cases had normal body mass index (BMI, range 20--25), whereas 15.6% were overweight and 33.6% were obese. Analysis of alcohol consumption indicated that 51% regularly consumed alcohol and 49% were nondrinkers. Similarly, analysis of smoking habits indicated that 48% of these cases were smokers/former smokers, whereas 52% were nonsmokers. Of all cases, 87.8% did not report relatives with cancer, whereas 12.2% reported first-degree relatives with cancer. Out of 155 patients with cancer family history, 55 cases fulfilled the criteria for Lynch syndrome and 7 cases fulfilled the criteria for familial adenomatous polyposis^\[[@R26]\]^ (data not shown).
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Demographic and risk factor data in 1525 Colombian colorectal cancer cases.
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3.2. Histological features and TNM staging
------------------------------------------

Out of all cases, information about tumor location was readily available in 931 cases and information about tumor stage in 511 cases. For 735 cases, the source of histopathological information (histopathology reports) was biopsies, whereas for 543 cases reports were available from surgical resections. Therefore, we were able to analyze TNM staging only in a subset of 488 patients with complete histopathological reports from surgical specimens. Table [2](#T2){ref-type="table"} summarizes the main clinical and histological characteristics of the tumors belonging to the participant cases in our study. Tumors in our Colombian cases occurred more frequently in the rectum (42.7% of the cases had rectal tumors compared with 30% with distal and 27.3% with tumors at the proximal location). The most common tumor type was the adenocarcinoma, diagnosed in 91.5% of the cases, followed by mucinous carcinoma in 5.2% cases and carcinoma with signet ring cells histology in 1.6% of cases. Other histological subtypes included squamous cell carcinoma and neuroendocrine tumors, which accounted for 1.7% of the cases (data not shown). We also found that 79.8% of the cases had advanced stages and 20.2% had early-stage tumors. The analysis of the lymph node metastasis, however, indicated that 63.7% reported no lymph node involvement, whereas 36.3% included involvement of 1 or more nodes. We found an average of 10.7 lymph nodes were examined per case (data not shown), in contrast to recommended examination of a minimum of 12 lymph nodes. However, for advanced rectal cancer, the number of cases with lymph nodes examined in this cohort was 42.7% and such cases were mostly treated with preoperative radiotherapy. We acknowledge that this approach can diminish the amount of lymph nodes dissected at the surgical specimen, and lymph node clearance was not done as a rule in the surgical specimen study. Table [2](#T2){ref-type="table"} also shows that, based on TNM classification, advanced tumors were diagnosed in more than 40% of all cases.
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Clinical and histological characteristics of the Colombian cases included in the study.
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3.3. Differences in clinical manifestations by the sex and age of onset
-----------------------------------------------------------------------

Intrigued by a higher proportion of female cases in our study, we decided to analyze the clinicopathological characteristics, stratified by sex. Table [3](#T3){ref-type="table"} shows the results of these comparisons. We found that female cases, when compared with male cases, were more likely to be diagnosed with early-onset CRC (30% vs 23%; *P* = 0.005), to have a normal weight at time of CRC diagnosis (55% vs 46%; *P* = 0.001), to report a family history of cancer (15% vs 10%; *P* = 0.016), and to be diagnosed with localized tumors (24% vs 16%; *P* = 0.036). Table [4](#T4){ref-type="table"} shows the results when analyses were stratified by age of onset (early onset vs late onset). As expected, most early-onset cases were women, who represented 59% of these cases. Early-onset cases, compared with older cases, reported more often family history of cancer (17% vs 10%; *P* = 0.001), had more rectal tumors (49% vs 40%; *P* = 0.012), were less likely to be diagnosed with proximal tumors (21% vs 30%), and had a higher fraction of mucinous or signet ring cell tumors (14% vs 5%; *P* \< 0.001).
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Clinical and demographic characteristics stratified by the sex of the case.
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Clinical and demographic characteristics, stratified by the age of onset of the case.
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4. Discussion
=============

In this study, we carried out a comprehensive evaluation of the clinicopathological features in, what is, to our knowledge, the largest existing cohort of Hispanic CRC cases. The study was conducted by sampling more than 1500 incident cases from several Colombian regions, in which we collected and analyzed several demographic, clinical, and pathological variables. Our study uncovered important key features of Colombian CRC cases such as a significant proportion of individuals (26.5%) had early-onset disease and a large fraction of cases were female, had rectal tumors, and advance disease.

One of the most striking finding of the study was the presence of a higher fraction female CRC cases (53.2% women vs 46.8% men). This is in contrast to reports from developed countries, including reports on US Hispanics, where men are more often diagnosed with CRC.^\[[@R3],[@R14],[@R27]--[@R29]\]^ Our findings are, however, consistent with previous reports suggesting a higher CRC incidence in Colombian women.^\[[@R5],[@R14]\]^ Interestingly, when we carried sex-stratified analysis, we found that compared with men, a statistically significant higher proportion of female cases had normal BMI at CRC diagnosis (55% vs 46%), diagnosed at younger age (30% female cases had early-onset CRC, compared with 23% males), and reported higher family history of cancer (15% vs 10%). Our findings of a higher proportion of female CRC cases having normal BMI are consistent with previous studies that failed to detect consistent association between obesity and CRC cases in females, in contrast to males.^\[[@R30]\]^ Various genetic and environmental factors such as diet, hormonal exposure, reproductive history, and willingness to seek medical help may contribute to these sex-related disparities. However, case-control and cohort studies are clearly needed to understand these sex differences in Hispanic CRC cases from Latin America.^\[[@R31],[@R32]\]^

Our Colombian cases were also unique in terms of age at CRC onset. The average age of CRC diagnosis in our cohort was 57.4 years, with 26.5% of cases diagnosed with early-onset disease. These findings are in contrast to cases from the developed countries where the average age at CRC diagnosis ranges from 64 to 72 years.^\[[@R33]\]^ However, our findings echo the recent evidence that suggests rise in early-onset CRC cases, specifically in US minorities like Hispanics.^\[[@R34],[@R35]\]^ Interestingly, early-onset cases in our study reported a family history of cancer more often than older cases (17% vs 10%), indicating a possible role of a genetic predisposition. Indeed, we have carried small-scale genetic studies in some of these individuals and have identified carriers of mutations in highly penetrant genes.^\[[@R21],[@R23]\]^ Early-onset cases were also enriched for tumors of mucinous and signet ring subtypes (14% vs 5%), tumor types that are known to be more aggressive and have poor prognosis.^\[[@R36]--[@R38]\]^ A higher fraction of early-onset cases in Colombia could partly reflect the demography of the country, which has a larger fraction of younger individuals than countries in the developed world.^\[[@R39]\]^ Nonetheless, other factors such as environment, heredity, lifestyle, and ancestry, which could play a role in early-onset disease, need to be further studied in this population.^\[[@R40]\]^ Our findings of a high fraction of early-onset cases and their aggressive tumor types strongly support the need to modify screening strategies to include younger Colombian individuals.^\[[@R35],[@R41]\]^ Additionally, molecular testing to screen for mutations in CRC predisposition genes could also benefit better understanding of the etiology and management of early-onset cases.

A third interesting finding of our study was the large fraction of cases with rectal tumors (42.7%). Similar to previous studies, early-onset cases were more commonly diagnosed with rectal tumors (49%).^\[[@R34],[@R42]\]^ Patients with distal and rectal CRC, in addition to presenting symptoms earlier and differences in prognosis, show different embryological origin, digestive function, and gene expression, when compared with those tumors at other locations.^\[[@R43],[@R44]\]^ As the cases in this study were not identified as a result of screening, it is likely that the high proportion of rectal and distal cases could be explained by the presence of symptoms such as bleeding and changes in bowel habits, which cause patients to consult a physician earlier.^\[[@R45]\]^ The majority of our cases also had advanced stages of tumor (T3--T4, 79.8%) that could explain the high rate of mortality in countries with limited resources like Colombia.^\[[@R46],[@R47]\]^

We also acknowledge the limitations of the study, including the fact that full data collection was not possible due to incomplete clinical records in the hospitals from this limited-resource country. Furthermore, even though all patients were in person interviewed by trained nurses, an important fraction of such interviews occurred during hospital visits when the patients could not readily provide accurate information due to time limitations for the interview or poor/difficult state of the patient. We also acknowledge that future studies should carry out a population-based approach, but given the limited number of cancer registries existing in the county, such studies are likely to be very difficult. Because our study was carried out in large cancer hospitals from the main cities, we are confident that it reflects the most common characteristics of CRC cases in Colombia. Furthermore, because medicine in Colombia is socialized, we are confident our results are representative of the main clinical characteristics of CRC cases from the entire Colombian population. Despite some of these limitations, we believe that our large study uncovered many interesting and unique clinicopathological characteristics of Colombian CRC patients that are worth following up in future clinical and epidemiological studies.

In summary, our findings, in a large sample of Hispanic patients from a multicenter study, highlight some of the key clinicopathological features of CRC cases from a developing country such as Colombia that will be helpful in further understanding the causation and designing better strategies for CRC diagnosis and management. More extensive epidemiological and molecular studies are needed to allow a better understanding of CRC etiology in this Hispanic population.

We are grateful to all of the individuals who participated in the study and to the many research nurses, study coordinators, and clinicians who helped during patient recruitment and data collection. During the preparation of this manuscript, Dr Rodrigo Prieto, our friend, colleague, and co-author passed away. This study is dedicated to his memory.

Abbreviations: ASR = age-standardized rates, BMI = body mass index, CRC = colorectal cancer, TNM = tumor, lymph node, metastasis.

Rodrigo Prieto, In memoriam.
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